MLYS- Mineralys Therapeutics, Inc.

Name: Mineralys Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Mineralys Therapeutics, Inc. (MLYS) has 8 insiders with recent SEC Form 4 filings, including 2 buys and 12 sells. MLYS is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Slingsby Brian Taylor	7.90M	$208.23M	-
Dir	Ra Capital Management, L.P.	5.46M	$143.75M	-
CEO	Congleton Jon	689.3K	$18.16M	-
Dir	Akkaraju Srinivas	588.2K	$15.50M	-
Other	Rodman David Malcom	57.1K	$1.50M	-14,474

Activity

Buys and sells only

Transactions

10 filings · page 3

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Sep 15, 2025	Rodman David Malcom56	Chief Medical Officer	Sell	11,367	$36.00	$409,265.98	-6.4%	-0.5%	-
Sep 4, 2025	Ra Capital Management, L.P.53	Director	Buy	1,176,470	$25.50	$29,999,985.00	+27.5%	+18.4%	-
Sep 4, 2025	Akkaraju Srinivas81	Director	Buy	588,235	$25.50	$14,999,992.50	New	+18.4%	-
Aug 13, 2025	Rodman David Malcom56	Chief Medical Officer	Sale+OE	11,365	$12.93	$146,986.95	-10.9%	+247.4%	-
Jul 30, 2025	Levy Adam Scott	CFO And Secretary	Sell	73,678	$14.62	$1,077,476.77	-10.0%	+180.7%	-
Jul 14, 2025	Rodman David Malcom56	Chief Medical Officer	Sale+OE	11,366	$14.59	$165,878.81	-10.4%	+186.6%	-
Jul 11, 2025	Congleton Jon47	Chief Executive Officer	Sell	15,884	$14.51	$230,430.78	-1.8%	+171.8%	-
Jul 11, 2025	Levy Adam Scott	CFO And Secretary	Sell	10,758	$14.45	$155,454.18	-4.9%	+171.8%	-
Jun 13, 2025	Rodman David Malcom56	Chief Medical Officer	Sale+OE	11,366	$14.60	$165,931.10	-10.1%	+159.5%	+64.9%
May 14, 2025	Rodman David Malcom56	Chief Medical Officer	Sell	11,366	$15.29	$173,773.64	-9.6%	-10.6%	+80.5%

← PrevPage 3Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC